- Corporate Officers - M
- Mariani Peter J
Insider Trading History of Mariani Peter J
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mariani Peter J since 2012.
This trader's CIK number is 1222357.
At the time of last reporting, Mariani Peter J was the Chief Financial Officer of Cytosorbents Corp. (stock ticker symbol CTSO).
Also see all insider trading activities at Cytosorbents Corp.
Note that in the past
MARIANI PETER J also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Axogen, Inc. (AXGN) by Mariani Peter J
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | AXGN | 0 | $0 | 118,299 | $1,137,805 | 146,386 | $633,202 |
2022 | AXGN | 0 | $0 | 10,649 | $126,510 | 13,625 | $0 |
2021 | AXGN | 0 | $0 | 0 | $0 | 4,525 | $0 |
2020 | AXGN | 0 | $0 | 77,457 | $970,303 | 60,000 | $302,400 |
2016 | AXGN | 3,333 | $24,997 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Hansen Medical Inc (HNSN) by Mariani Peter J
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | HNSN | 0 | $0 | 43,435 | $99,900 | 0 | $0 |
2013 | HNSN | 0 | $0 | 7,424 | $16,600 | 0 | $0 |
2012 | HNSN | 0 | $0 | 6,348 | $20,104 | 0 | $0 |
Yearly summary of insider trading at Cytosorbents Corp (CTSO) by Mariani Peter J
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2024 | CTSO | 51,363 | $47,281 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Mariani Peter J:
1. Axogen, Inc. (AXGN)
2. Hansen Medical Inc (HNSN)
3. Cytosorbents Corp (CTSO)
Table 1. Insider trading of Axogen, Inc. (AXGN) by Mariani Peter J
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-12-11 | AXGN | Sale | 12,500 | 7.51 | 93,875 |
2023-03-16 | AXGN | Option Ex | 20,750 | .00 | 0 |
2023-01-31 | AXGN | Sale | 14,320 | 9.55 | 136,756 |
2023-01-30 | AXGN | Sale | 14,111 | 9.69 | 136,735 |
2023-02-01 | AXGN | Sale | 14,550 | 9.36 | 136,188 |
2023-01-31 | AXGN | Option Ex | 20,939 | 5.04 | 105,532 |
2023-01-30 | AXGN | Option Ex | 20,939 | 5.04 | 105,532 |
2023-02-01 | AXGN | Option Ex | 20,940 | 5.04 | 105,537 |
2023-01-25 | AXGN | Option Ex | 20,939 | 5.04 | 105,532 |
2023-01-26 | AXGN | Option Ex | 20,939 | 5.04 | 105,532 |
2023-01-25 | AXGN | Sale | 20,939 | 10.23 | 214,205 |
2023-01-27 | AXGN | Option Ex | 20,940 | 5.04 | 105,537 |
2023-01-26 | AXGN | Sale | 20,939 | 9.90 | 207,296 |
2023-01-27 | AXGN | Sale | 20,940 | 10.16 | 212,750 |
2022-12-27 | AXGN | Option Ex | 2,625 | .00 | 0 |
2022-11-16 | AXGN | Sale | 10,649 | 11.88 | 126,510 |
2022-03-16 | AXGN | Option Ex | 11,000 | .00 | 0 |
2021-12-27 | AXGN | Option Ex | 2,625 | .00 | 0 |
2021-12-20 | AXGN | Option Ex | 1,900 | .00 | 0 |
2020-12-29 | AXGN | Sale | 1,293 | 17.81 | 23,028 |
2020-12-21 | AXGN | Sale | 481 | 16.42 | 7,898 |
2020-10-30 | AXGN | Option Ex | 60,000 | 5.04 | 302,400 |
2020-10-30 | AXGN | Sale | 75,683 | 12.41 | 939,377 |
2016-10-07 | AXGN | Buy | 3,333 | 7.50 | 24,997 |
Table 2. Insider trading of Hansen Medical Inc (HNSN) by Mariani Peter J
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-02-26 | HNSN | Sale | 43,435 | 2.30 | 99,900 |
2013-03-05 | HNSN | Sale | 7,424 | 2.24 | 16,600 |
2012-03-01 | HNSN | Sale | 6,348 | 3.17 | 20,104 |
Table 3. Insider trading of Cytosorbents Corp (CTSO) by Mariani Peter J
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2024-12-13 | CTSO | Buy | 20,000 | .96 | 19,300 |
2024-12-11 | CTSO | Buy | 11,363 | .89 | 10,101 |
2024-12-12 | CTSO | Buy | 20,000 | .89 | 17,880 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Mariani Peter J
(Chief Financial Officer of Cytosorbents Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.